欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号PT/H/1309/001
药品名称Fulvestrant Sandoz
活性成分
    • Fulvestrant 50.0 mg/ml
剂型Solution for injection
上市许可持有人Sandoz Farmacêutica, Lda.
参考成员国 - 产品名称Portugal (PT)
互认成员国 - 产品名称
    • Germany (DE)
      Fulvestrant - 1 A Pharma 50 mg/ml Injektionslösung
    • Denmark (DK)
    • Belgium (BE)
      Fulvestrant Sandoz 250 mg oplossing voor injectie, voorgevulde spuit
    • Netherlands (NL)
    • Iceland (IS)
      Fulvestrant Sandoz 250/5 mg/ml Stungulyf, lausn
    • United Kingdom (Northern Ireland) (XI)
    • Ireland (IE)
    • Austria (AT)
      Fulvestrant Sandoz 250 mg Injektionslösung in einer Fertigspritze
    • France (FR)
    • Spain (ES)
    • Italy (IT)
    • Sweden (SE)
    • Norway (NO)
    • Finland (FI)
    • Poland (PL)
    • Lithuania (LT)
      Fulvestrant Sandoz 250 mg injekcinis tirpalas užpildytame švirkšte
    • Estonia (EE)
      FULVESTRANT SANDOZ
    • Hungary (HU)
      FULVESTRANT SANDOZ 250 mg oldatos injekció előretöltött fecskendőben
    • Bulgaria (BG)
      Fulvestrant Sandoz
    • Czechia (CZ)
      Fulvestrant Sandoz 250 mg
    • Slovakia (SK)
      Fulvestrant Sandoz 250 mg
    • Slovenia (SI)
    • Croatia (HR)
      Fulvestrant Sandoz 250 mg otopina za injekciju u napunjenoj štrcaljki
许可日期2015/08/05
最近更新日期2024/11/07
药物ATC编码
    • L02BA03 fulvestrant
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
    市场状态Positive
    ©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase